RxDoctor Payments Data

David Ludden, MD

Cardiovascular Disease · la Crosse, WINPI 1073773834

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $55,200 of the $58,736 with a category attached, or 94.0%. Medical Device Business Services, Inc. accounts for 73.8% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $33,140 and has fallen 62.2% since, to $12,538 in 2025. Among cardiovascular disease clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$58,736in general payments, 2019–2025

Across 64 payments — averaging $917.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$43K
  • Biosense Webster, Inc.$13K
  • Medtronic$2K
  • Abbott$172

What the payments were for

  • Consulting fees$55,20094%
  • Travel & lodging$8681%
  • Food & beverage$2,6685%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medical Device Business Services, Inc.21$43,365
Biosense Webster, Inc.14$12,869
Medtronic(2 entities)27$2,331
Abbott2$172

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$58,736 in reported general payments places this provider in the 95th percentile of 322 cardiovascular disease providers in Wisconsin.

See all cardiovascular disease providers in Wisconsin

Medicare billing

Part B allowed, 2024
$117,604
Medicare patients
501
Services billed
1,018

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban24$24,324
Metoprolol Succinate46$831
Mupirocin41$646
Amiodarone Hcl17$639

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in la Crosse

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →